Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There is so much that can be done once financials are current it’s insane, josh can do so much to make Mobicard a top dog.
Look at the bright side guys, the potential here is really MASSIVEEE once PTOP gets current and the company gets certain stepping stones going, Mobicoin, imagine that with Mobicard for the future, your looking at millions or hundreds of millions of CRYPTOCURRENCY buyers who would gain an interest in Mobicard Due to Mobicoin, I am saying it would give large incentive to the Mobicard app for Massive users, it would give large incentive to Businesses.
And the app is being redesigned with improvements according to the CTO on the last PR so that is exciting.
Great things coming for those who are patient.
Any new investors on this board, now or later, Welcome!
I guess that’s the million dollar question and you are apsolutely right, that’s a good question.
Well there’s nothing I can do with my 60 million restricted shares so an investor like me can only hope that they get a handle on things and also this time around, attract a MASSIVE UserDatabase, that’s my hope since I’m stuck on my restricted shares but it is what it is, I hope things turn around, and the past few years made us all quite butthurt, I was feeling it that’s for sure but they have a opportunity to turn things around now, definitely with PTOP getting pink/current, they could get some serious funding, if josh gets his 5 million dollars, there is quite a lot that he could do with such a pack of cash so just imagine that.:)
Let’s hope the right decisions are made going forward, that would make us all happy and excited.
I agree, this mentality I share also.
My question is, so you understand there is LinkedIn and ofcourse they don’t offer what Mobicard can offer but in there own way, they offer something we don’t offer like they have an educational program they do and much more on LinkedIn.
I’m not comparing, I am stating the obvious and to say that Mobicard has to offer something that draws users in the masses like LinkedIn for example, Mobicard needs serious users once platform is ready and on the App Store but I am unsure if Mobicard alone is an incentive to get people involved. I think there needs to be an attractive incentive for newbies and newcomers to want a piece of Mobicard and what better incentive is there than a Cryptocurrency named Mobicoin, I think Mobicoin side by side with Mobicard would add strong Marketing to a legit and strong marketing campaign and, you mix Mobicard and Mobicoin together in future marketing and use both of them as a strong benefit of being a user of the Mobicard.
I think there is serious benefits to the Mobicoin and using it to add value, and to add longevity and users in the MASSES if you use Mobicoin properly with Mobicard.
Also if you use Mobicoin and offer businesses a better deal, if you design Mobicoin where businesses with customers and everything have a opportunity to gain more and gain money by gaining Mobicoins in a business aspect, than it would also make Mobicard more attractive to business, you know as you stated, Enterprise Accounts, Link Mobicoin as a strong benefit for businesses owning Enterprise accounts for all there employees, give serious incentive for them to want to use the MOBICARD, Mobicoin being a strong incentive.
These are smart business tactics, this is my opinion.
The news article might get some pharma attention, I likeyy!!
Yes but the fda is now recognizing it and it was put on the FDA news today officially as a article, this is good.
FDA HEALTH NEWS, TSOI NEWS ARTICLE POSTED TODAY! Company is starting to catch big eyes.
https://fdahealthnews.com/stories/564771295-therapeutic-solutions-international-jadicell-stem-cells-licensed-by-therapeutic-solutions-international-for-brain-injury-significantly-increased-survival-of-covid-19-patients-in-double-blind-fda-clinical-trial
Not sure I agree with anything you can say but all I can say is 1 aspect of what you said,Once Mobicard is on the stores, there needs to be serious user database increase and a flow of Revenue, PTOP cannot survive on investor money forever, there Apsolutely has to be a form of Revenue the company has flowing in for PTOP to have a serious future.
Tonight at 7pm eastern time Twitterspace with CTO of $PTOP right here at
@freemobicard
Live Questions session
I think there is a lot of exaggeration from those people, I’m pretty sure an audit realistically could take weeks or a few months, it sounds more realistic so I wouldn’t trust those people and if they actually got an app in the App Store in a few days, it’s probably because they had somebody to push there app on the inside, somebody that worked with them and works for Apple or maybe they payed Apple money to push there app faster through the process, I’m sure there is loopholes people use to make the process faster.
You know the saying, money speaks volumes.
Audits can take a decent amount of time.
Comon man, don’t call me josh, I don’t appreciate that considering I’ve been an investor here for years, I am not going to play fantasy land and act like this hasn’t been hard on me because I don’t think this has been easy to handle in any shape or manner but I’ve been invested hard, 60 million restricted shares is a big investment.
I pray things turn out great and from where I’m sitting now, I see that yield sign, I remember josh was talking about getting 5 million dollars once current awhile back so that would be a big BIG positive, I think that this company needs some serious funding to get going on a serious basis, realistically. So this would be a great step forward.
Revenue is the trick when Mobicard gets back on the stores and REVENUE actually starts flowing in from a growing user base, when i say growing I mean there has to be a serious increase in users, 10,000 here, 50,000 there and growing and growing, serious marketing, serious incentive for people to want to use the Mobicard, it needs to EXPAND hardcore. Once revenue is shown and results, investors will flock in and fall in love with this company like it’s there baby.
I am a normal investor with a normal job, I work at a paper mill so no I don’t in no capacity know inside info or anything, I stay up to date with everything said on the forum though daily.
Tomorrow I tend to buy 700 dollars worth of more shares, I just pay my apartment bills and put my extra money into TSOI monthly so just trying to lower my overall cost base average right now, it’s a good time to buy more shares, cheap price and all.
That was Tim stating they have all the Jadicells needed for trials, they have cryofreezers right now they are using, a lab will be storing much much more for all the sciences instead of just focusing the current 1 science for cryfreezing right now, so it’s all good, no worries at all.
Answer to the LAB question by Tim:
Cells for clinical trial are made and cryopreserved. Our future lab will generate cells for use beyond the clinical needs of the phase 3.
I see a real possible good path forward with a strong momentum in going forward share price driving up.
There is a ticker to what I speak of though, the main ticker is, PTOP is going to have to show results on the mobicard and and serious plan Revolving around Revenue, because Revenue is what drives companys forward and PTOP needs to be a profitable company. If Josh gets his 5 million dollars and shows serious results going forward than this company could be looking at a seriously bright future, this is my perspective.
All this depends on josh.:)
Tim just said on the Forum:
I am saying that the end game here is full approval by FDA to be used within the general population with "lung disease" not covid-19 ARDS although that would be included and so would ARDS caused by other things like with pneumonia, inhaling salt water, and other toxic things.
Lung disease includes disease like COPD. There are 16 million Americans who have COPD. There are 65 million humans worldwide who have COPD. All of these are lung diseases: asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, bronchitis, pulmonary fibrosis, sarcoidosis, hypertension, pneumonia, pulmonary edema, pulmonary embolus, influenza.
So to repeat for clarity, the Phase 3 trial, assuming we meet our end-points, is to seek registration of the cell to be used in the general population with lung diseases which includes all of the above.
I spoke to Tim on the forum and.
THIS PUTS ME AT EASE BIGGGG TIME!!!!
Jadicell is like a hybrid cure in a sort of way, Jadicell can cure covid patients with lung damage/ARDS once they get EUA approval and or clinical trials finished and or Both.
ANDDD, Even, EVENNN if covid disappears, and is no longer around, our Jadicell for covid lung damage/ARDS and let me EMPHASIZE, “ARDS” ”ARDS”
meaning there is a lot of people every day, hundreds with ARDS Lung issues that are not COVID relatee, NOT Covid related, all the time.
even if COVID goes away, our Jadicell will still be a extremely effective treatment and will still be able to treat people.
LISTEN, the reason why is because ARDS falls into the Covid and NON-COVID meaning it counts for both COVID and EVEN if covid disappeared patients, NON COVID, regular people of society with ARDS
I wonder what caused so insane buying power today, anyone have a clue?
You guys really like your drama don’t you, I am turning a blind eye and imagining all you ladies are saying is, Bla bla bla, jibber jabber drama language.
Josh has the capability of turning things around, I’m not saying anything negative or positive so to speak, I am speaking of the neutral zone, it can happen, I believe he has a plan and I believe he could do some really great things to turn this into a profitable business through Mobicard. So I’m just going to chill, go drink a beer and watch while the PTOP fireworks go off more and more as time goes on.
What I meant is there is not a single other company, pharma or biotech that has gotten anything Jadicell related to phase 3 on this earth, TSOI will be the first, and from the results you know as well as I do cuz they’re plastered all over the PR’s. The efficacy of Jadicell being 100% age 85 and below and over 85 is 91% with 0 that is NO side effects, most other drugs are a 50-70% efficacy rate with side effects so this is a huge deal for making proper calculation on this Jadicell and the future, TSOI is working on many fronts in Jadicell, CTE, stemvacs-V and breast cancer, this is new science and in my opinion, with the efficacy results you are seeing for this 1 Jadicell for covid lung damage/ARDS, I do not see any reason why Jadicell won’t be just as efficient with all there other treatments also going through the phases in all there other fronts/sciences they’re working on involving Jadicell, TSOI has more parents on Jadicell than anyone else.
So I will tell you my honest opinion, and it is that Jadicell is going to be a new science coming to medical industry in many treatment methods in the next years to 5-10-15 years and such, Jadicell in treatments will most likely become the new best treatment down the road in many ways because it’s already showing to dominate everything else in efficacy and no side effects, TSOI is ahead of the curve compared to any single other competitor on earth, we are a small dog right now but you could honestly see hundreds of dollars in the share price down the road, in 10 years, many hundreds of dollars in the share price is very realistic for TSOI at the rate they’re going with all these Jadicell treatments and getting them through the FDA processes.
It’s been around but no biotechs or pharma has gotten into the jadicell, TSOI has gotten further than anybody else, why do you think the FDA requires more information on Jadicel before giving the go ahead to initiate phase 3 clinical trials for TSOI, why do you think that the FDA required more info than they ask of lost company’s, that’s because Jadicell is Unknown territory and the FDA are being cautious/were being cautious, now they trust it a little more and they approved TSOI to go to phase 3. Happy days ahead, this company is ahead of all other company’s on earth on the Jadicell subject of science, in general.
Download thinkorswim and log into your TD account, you will see the PR from this morning.
I use thinkorswim app, and that’s for TD Ameritrade account, it shows the latest news is 10-11-21 so not sure where you are getting your inaccurate information about latest news showing 10-4-21
I am also buying more, stocking up baby.
Well that just really sucks, but josh has stated many times in the past that a Reverse Split is in the books, let’s hope for a Reverse Split once financials are Pink, Current, once a Reverse Split happens it’ll be a much more attractive investment to other investors in general, it’ll be good for the future of this company and also it’ll benefit us Restricted shareholders because we will be able to deposit our shares.
$PTOP josh said on twitter under Mobicard. 23 hours ago:
We are in compliance with SEC amendment 15c2-11 awaiting OTC “pink current status” Announcement soon to come…
Well not getting into these drama discussions but on a side note, my concern is this, I own 60 million restricted shares and I have been told that we will not be able to unrestrict our shares until a .01 share price or higher because the brokers won’t even accept restricted shares under .01 so that’s a problem for me, can anybody give me some insight, is there any way I will be able to unrestrict my shares after financials are complete at the current price, I’m just wondering because if this stock has to be .01 or higher, I guess we will have to wait for a reverse split or crazy amazing things to happen with this company, 1 of the 2
It’s not Christmas yet.;)
I agree that TSOI is the 1 OTX worth holding, this is the diamond in the haystack, so with patience this will be our winning lottery ticket, yep.
It wouldn’t matter whether you have TSOI on your watch list or not because you being on this board is no different from watching TSOI on your watchlist, you can see the price and the PR’s from this board. Also I don’t think your going to stop chatting on this board anytime soon, your the TSOI chat addict afterall. :DD because you chat like A speed crazy person on this board every day, 20-30 different chats on the board daily, so Excessive would be cutting it short, but your very intellectual on the company so I’ll give you credit, I’m also an Extreme Long, LOVE $TSOI
There is many things in the pipeline and a partnership is a real possibility, also imagine once EUA filing and approval, instant dollar to dollars over a week period and than up and up from there. TSOI will become the top article on all news stations in the country when we get EUA approval, it’ll be massive!
And imagine all the other stuff in the pipeline I realistically see many many dollars up to a possible 10 dollar SP in 1-3 years. Maybe less, it’s always a possibility but I see this as a no brainer for a 1-3 year hold and extreme return ratio.
The yield sign is still up, we are waiting for the yield to be turned into a Pink current sign, than it’s go time toward the future and josh probably has a lot up his sleeves, hoping for a good end of 2021-2022
Once EUA filing it should be a grantees approval than instant dollars in the matter of a week to weeks. Each patient will equal 20,000 dollars so 1000 patients treated will equal 20 million dollars, add it up because there is hundreds of thousands of patients in the USA alone that need treating, up to 1-2 million and growing.
Also TSOI has better results than all other Biotechs, if you want to look on a realistic basis, look at it like this, TSOI has already got everybody else beat on the Efficacy rate and No side effects factor, most drugs have side effects, and almost ALL drugs do not have a 100% efficacy cure rate age 85 and below and 91% efficacy cure rate over age 85 so that speaks massive volumes, in my honest opinion if you want to pick between 100 biotechs for a investing option I would say TSOI has the meat to make it to the end compared to all the other small and big dog biotechs, the reason I say that is because also NO SIDE EFFECTS! TSOI has what no other biotech does, a form of treatment now that is pretty much a guaranteed survival rating, and after treatment you will be in perfect shape because no side effects, no nothing.
I’d say TSOI is the winning lottery ticket for the patient investor, just my opinion…. :D
$TSOI
hey guys, if you have Facebook look at this TSOI, Nanostilbene video posted 13 hours ago. this is a really good video and it’s getting recognized, the company’s products.
Link here: https://fb.watch/8iuj1gUAa8/
I was reading some news and websites and Stuff and the word is, after September 28 when all non current OTC’s are removed, Only the real deal OTC’s will be left, a lot of INVESTMENT FIRMS and Millions of normal investors have always been hesitant to invest in OTC companies due to the HIGH RISK factor, after September 28 the risk factor will become A lot lower due to the fact only the REAL DEAL companies will be left.
The “WORD” is, HUNDREDS OF MILLIONS if not BILLIONS of dollars per year, will be dumped into OTC market after SEPTEMBER 28
All this stuff will be shown in the quarterly financial reports. Things are just fine, we all know Tim is making decisions that are right for us, we all know he has no intention of hurting us shareholders, he never does things that is bad for us, he has the share price and our future close at heart.
No worries here guys, we have the right CEO to aim this ship to success, all is good.
What do you mean by insiders, do you mean insiders as in Tim Dixon and the people in charge of the company or do you mean people that own restricted shares. If you mean the insiders as in Tim Dixon and all, can you prove that they are dumping shares because I’m not just going to listen to false words without proof to back it up.
Once Mobicard on Apple store, and good marketing, once josh gets his 5 million. If josh can get the user database expanding big time and actually get serious REVENUE from Mobicard, this company will have a future, Revenue equals future for the company, non revenue equals failure, it’s plain and simple, REVENUE REVENUE!! It’s what drives a company forward, revenue from Product, in this case our PRODUCT Is MOBICARD and revenue is what will provide a future for the company and for Mobicard.